GPC Biotech
GPC Biotech[edit | edit source]
GPC Biotech was a biotechnology company focused on the discovery and development of new cancer therapies. The company was founded in 1997 and was headquartered in Martinsried, Germany. GPC Biotech was known for its work in developing innovative treatments for cancer, particularly in the area of oncology.
History[edit | edit source]
GPC Biotech was established as a spin-off from the Max Planck Institute of Biochemistry. The company quickly gained attention for its research and development efforts in the field of cancer therapeutics. In the early 2000s, GPC Biotech expanded its operations to the United States, establishing a presence in Waltham, Massachusetts.
Research and Development[edit | edit source]
GPC Biotech focused on the development of novel anticancer drugs. The company's research efforts were primarily directed towards the discovery of small molecules and biological therapies that could target specific pathways involved in cancer progression.
Drug Development Programs[edit | edit source]
One of the most notable projects undertaken by GPC Biotech was the development of satraplatin, an oral platinum-based chemotherapy drug. Satraplatin was designed to treat patients with prostate cancer who had become resistant to other forms of chemotherapy. Although satraplatin showed promise in clinical trials, it ultimately did not receive approval from the U.S. Food and Drug Administration (FDA).
Collaborations and Partnerships[edit | edit source]
GPC Biotech engaged in several strategic partnerships with other biotechnology and pharmaceutical companies to advance its drug development programs. These collaborations were crucial in providing the necessary resources and expertise to bring potential therapies to market.
Challenges and Closure[edit | edit source]
Despite its early successes, GPC Biotech faced significant challenges in the highly competitive biotechnology industry. The failure to secure FDA approval for satraplatin was a major setback for the company. In 2009, GPC Biotech merged with Agennix, another biotechnology company, marking the end of its independent operations.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
